EGRX Short Information, Eagle Pharmaceuticals Inc.

Twenty Trading Day Totals
Total Shorted Volume	239,628
Total Actual Volume	2,421,779

Averages
Average Short Volume	11,981
Average Short Percentage	62.68%

Is there a EGRX Short Squeeze or Breakout about to happen?

See the EGRX Short Analysis for free Sign up or Login

Stock Date	Open Price	Close Price	High	Low	Total Volume	Short Volume	Short Percentage
2021-09-23	51.35	54.03	54.66	51.045	122,530	7,922	37.0325
2021-09-22	49.96	51.45	51.56	49.86	86,901	8,232	53.0686
2021-09-21	49.12	49.85	50.01	48.56	37,510	2,824	76.8226
2021-09-20	48.47	49.03	49.5	48.44	93,976	8,967	53.1378
2021-09-17	51.13	49.28	51.13	48.89	365,919	16,730	65.4641
2021-09-16	52.94	51.1	52.94	50.95	149,276	12,941	44.9215
2021-09-15	54.02	52.88	54.46	52.53	128,984	9,786	53.4170
2021-09-14	52.45	53.91	54.07	52.45	103,651	14,870	92.2800
2021-09-13	51.89	52.35	52.68	51.05	104,021	12,098	92.0070
2021-09-10	51.505	51.7	52.19	50.27	108,960	13,912	80.9826
2021-09-09	51.51	51.95	52.13	50.71	154,563	8,819	62.8492
2021-09-08	52.08	51.55	52.1321	50.91	60,465	5,942	64.2934
2021-09-07	51.54	52.08	52.32	51.13	84,912	6,655	39.1102
2021-09-03	52.74	51.46	52.96	50.71	97,214	7,922	55.5735
2021-09-01	53.78	52.42	53.78	52.045	107,423	12,627	38.3159
2021-08-31	51.66	53.37	55.4999	51.66	287,280	45,452	49.9934
2021-08-30	47.27	48.42	48.42	47.27	70,748	6,874	81.6875
2021-08-25	49.2	48.39	50.46	47.71	93,951	17,080	73.1509
2021-08-24	50.52	49.21	50.76	48.87	58,711	7,545	74.4450
2021-08-23	49.97	50.68	51.01	49.9	104,784	12,430	64.9527

Stock Information

Eagle Pharmaceuticals Inc. Company Name:

EGRX Stock Symbol:

NASDAQ Market:

Get EGRX Alerts

News, Short Squeeze, Breakout and More Instantly...

EGRX - Reminder: Eagle Pharmaceuticals to Host CAL02 Investor Event on September 9, 2021

Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) will host an investor event, led by Scott Tarriff, Chief Executive Officer, and Judi Ng-Cashin, Chief Medical Officer, and will feature other guest speakers, to discuss the CAL02 opportunit...
EGRX - Eagle Pharmaceuticals to Present at September Healthcare Conferences

Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that Scott Tarriff, Chief Executive Officer, and Brian Cahill, Chief Financial Officer, will present at two upcoming investor conferences as follows: The presentatio...
EGRX - Eagle Pharmaceuticals Wins Vasopressin Patent Trial

Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that the U.S. District Court for the District of Delaware held that Eagle’s proposed vasopressin product does not infringe any of the patents Par asserted against the...